CLOPINOVO Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

clopinovo

errekappa euroterapici s.p.a. - clopidogrel - clopidogrel

CLOPIDOGREL ALTER Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

clopidogrel alter

laboratori alter s.r.l. - clopidogrel - clopidogrel

QUETIAPINA EG STADA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

quetiapina eg stada

eg s.p.a. - quetiapina - quetiapina

QUETIAPINA SANDOZ BV Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

quetiapina sandoz bv

sandoz bv - quetiapina - quetiapina

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Unione Europea - italiano - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - clopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - agenti antitrombotici - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segment elevation infarto miocardico acuto, in combinazione con asa in medicalmente trattati i pazienti eleggibili per la terapia trombolitica. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. per ulteriori informazioni, si prega di fare riferimento alla sezione 5.

APREPITANT ACCORD Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

aprepitant accord

accord healthcare, s.l.u. - aprepitant - aprepitant

ATANTO Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

atanto

sintesy pharma s.r.l. - aprepitant - aprepitant

QUETIAPINA LABORATORI ALTER Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

quetiapina laboratori alter

laboratori alter s.r.l. - quetiapina - quetiapina

Memantine LEK Unione Europea - italiano - EMA (European Medicines Agency)

memantine lek

pharmathen s.a. - memantina cloridrato - malattia di alzheimer - psychoanaleptics, , altri farmaci anti-demenza farmaci - trattamento dei pazienti con malattia di alzheimer da moderata a severa.

FREKIDIR Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

frekidir

pharmathen s.a. - sitagliptin - sitagliptin